Cargando…

Can we be SMaRT-er in our approach to cancer therapy?

Detalles Bibliográficos
Autores principales:	Gruber, Christina, Hofbauer, Josefina Piñón, Bauer, Johann W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534698/ https://www.ncbi.nlm.nih.gov/pubmed/26288827 http://dx.doi.org/10.1016/j.ebiom.2015.06.002

Ejemplares similares

Linked in: the extracellular matrix network in tumour dissemination
por: Leb‐Reichl, V., et al.
Publicado: (2020)

Can We Hang Our Hats on One Percent?
por: LeVasseur, Nathalie, et al.
Publicado: (2018)

Diagnosing diagnoses – can we improve our taxonomy?
por: Borkent, Art
Publicado: (2021)

Hypothermia, immune suppression and SDD: can we have our cake and eat it?
por: Polderman, Kees H
Publicado: (2011)

SMaRT modulation of tau isoforms rescues cognitive and motor impairments in a preclinical model of tauopathy
por: Muñiz, Javier Andrés, et al.
Publicado: (2022)

SmaRT2P: a software for generating and processing smart line recording trajectories for population two-photon calcium imaging
por: Moroni, Monica, et al.
Publicado: (2022)

Transcriptome-Guided Drug Repurposing for Aggressive SCCs
por: Zauner, Roland, et al.
Publicado: (2022)

Palliative care for older people with dementia—we need a paradigm shift in our approach
por: Timmons, Suzanne, et al.
Publicado: (2022)

SMaRT lncRNA controls translation of a G‐quadruplex‐containing mRNA antagonizing the DHX36 helicase
por: Martone, Julie, et al.
Publicado: (2020)

Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa
por: Welponer, Tobias, et al.
Publicado: (2021)

Pandemic influenza: are we prepared to face our obligations?
por: Ehrenstein, Boris P
Publicado: (2008)

The WHO pandemic treaty: where are we on our scepticism?
por: Evaborhene, Nelson Aghogho, et al.
Publicado: (2023)

What we might accomplish by engaging in our local communities
por: Rosenthal, Marjorie Sue
Publicado: (2014)

GDNF Therapy: Can We Make It Work?
por: Björklund, Anders
Publicado: (2021)

Commentary: Pleurography: We can, but should we?
por: Benz, Cecilia, et al.
Publicado: (2021)

Commentary: Because we can
por: Hanna, Waël C.
Publicado: (2020)

Swine flu: lessons we need to learn from our global experience
por: Collignon, Peter
Publicado: (2011)

Innovations in tuberculosis diagnostics: How far are we from reaching our goal?
por: Varma-Basil, Mandira, et al.
Publicado: (2019)

Commentary: Firework related ocular trauma – Have we learnt our lessons?
por: Tekchandani, Uday, et al.
Publicado: (2021)

Commentary: we can tell where it hurts, but can we tell where the pain is coming from or where we should manipulate?
por: Brady, O’Dane, et al.
Publicado: (2013)

Can we measure catalyst efficiency in asymmetric chemical reactions? A theoretical approach
por: El-Fayyoumy, Shaimaa, et al.
Publicado: (2009)

Profiling trial burden and patients’ attitudes to improve clinical research in epidermolysis bullosa
por: Prodinger, Christine, et al.
Publicado: (2020)

Clinical and cost implications of using immediate MRI in the management of patients with a suspected scaphoid fracture and negative radiographs results from the SMaRT trial
por: Rua, T., et al.
Publicado: (2019)

Goal directed therapy: how long can we wait?
por: Gordon, Anthony C, et al.
Publicado: (2005)

Can we improve outcomes in AF patients by early therapy?
por: Kirchhof, Paulus
Publicado: (2009)

5′RNA Trans-Splicing Repair of COL7A1 Mutant Transcripts in Epidermolysis Bullosa
por: Mayr, Elisabeth, et al.
Publicado: (2022)

How a socio-ecological metabolism approach can help to advance our understanding of changes in land-use intensity
por: Erb, Karl-Heinz
Publicado: (2012)

Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes
por: Guttmann-Gruber, Christina, et al.
Publicado: (2018)

Peri-operative hemodynamic therapy: only large clinical trials can resolve our uncertainty
por: MacDonald, Neil, et al.
Publicado: (2011)

Salamanders and fish can regenerate lost structures - why can't we?
por: Simon, Hans-Georg
Publicado: (2012)

Long COVID: Does It Exist? What Is It? We Can We Do For Sufferers?
por: Hoffer, Edward P.
Publicado: (2021)

Commentary: Just because we can, doesn't always mean we should
por: Nellis, Joseph R., et al.
Publicado: (2021)

Are we slowly erasing “Idiopathic” from our ophthalmic vocabulary?
por: Meyer, David
Publicado: (2012)

The Next Influenza Pandemic: Will we be Ready to Care for Our Children?
por: Woods, Charles R., et al.
Publicado: (2005)

What can we do about osteoarthritis?
por: Lohmander, L Stefan
Publicado: (2000)

Pharmacy Internships: We Can Do Better
por: Nisly, Sarah, et al.
Publicado: (2018)

Doing What We Do, Better: Improving Our Work Through Systematic Program Reporting
por: Koek, Irene, et al.
Publicado: (2018)

Medical Staff Responses to COVID-19 ‘Data’: Have We Misplaced Our Skeptic's Eye?
por: Meisenberg, Barry R.
Publicado: (2021)

Climate-Smart Fiscal Policy Can Foster a Lasting Economic Recovery
por: Estevão, Marcello
Publicado: (2020)

A Novel Fluorescence-Based Screen of Gene Editing Molecules for Junctional Epidermolysis Bullosa
por: Zwicklhuber, Janine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mf0pmhf5fi8f7m8850iq93euqn